Lisa H. Lancaster, MD: The causes of ILD are very varied. We are looking for autoimmune causes. We’re looking for occupational or environmental exposures as well as family history in genetics that may play into this.
Alicia M. Hinze, MD: Within autoimmune diseases, we can see interstitial lung disease in actually several of our autoimmune diseases. So the one that we associate interstitial lung disease with the most would be systemic sclerosis, also called scleroderma. But there are other conditions or other autoimmune diseases that we often will see interstitial lung diseases in which would include rheumatoid arthritis, for example. We have seen it in cases of Sjögren’s syndrome. We’ve also seen it in cases, rarely but in lupus. And then there are some patients that have some more overlapping phenotypes where they don’t fit into a specific category but may have overlapping features that can also develop interstitial lung disease.
In regards to age, we do see most of our autoimmune diseases often occurring early in life. And so patients can present with autoimmune disease, scleroderma or even rheumatoid arthritis in their 20s, 30s, 40s. But in patients, for example, with idiopathic pulmonary fibrosis, these are often presenting after the age of 50.
Lisa H. Lancaster, MD: There are multiple comorbidities associated with interstitial lung disease. and as we assess patients for interstitial lung disease, and more specifically, idiopathic pulmonary fibrosis, we want to identify those comorbidities with key ones being pulmonary hypertension, uh, coronary artery disease, as well as gastroesophageal reflux disease, and obstructive sleep apnea.
Reflux disease has been linked with acute exacerbations and perhaps has been suggested to be a recurrent form of injury that may augment the disease process. Sleep apnea is just a floppy airway with desaturations occurring at nighttime that has been linked as well with both idiopathic pulmonary fibrosis and reflux disease. Assessing sleep in patients with idiopathic pulmonary fibrosis is important because what we’re doing is assessing their breathing during one-third of their day, which is their sleep.
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More